Fijnheer R, Frijns C J, Korteweg J, Rommes H, Peters J H, Sixma J J, Nieuwenhuis H K
Department of Hematology, University Hospital Utrecht, The Netherlands.
Thromb Haemost. 1997 Jun;77(6):1081-5.
P-selectin is a 140 kD protein found in the alpha-granules of platelets and the Weibel-Palade bodies of endothelial cells. On cell activation it is expressed on the cell surface and also secreted into plasma. Whether the circulating soluble P-selectin (sP-selectin) originates from platelets, endothelial cells, or both, is not known. We studied the level of sP-selectin in diseases with different platelet counts, with or without evidence of endothelial cell activation. Endothelial cell activation was confirmed by the detection of sE-selectin and ED1-fibronectin. A significant positive correlation between platelet count and sP-selectin concentration was observed in healthy controls, and in patients with thrombocytopenia due to bone marrow aplasia, or with thrombocytosis (r = 0.85; n = 47; p < 0.001). In patients with idiopathic thrombocytopenic purpura (ITP) the sP-selectin concentration was 110 +/- 39 ng/ml (n = 10), compared to 122 +/- 38 ng/ml in healthy controls (n = 26). However, their mean platelet count was lower (58 x 10(9)/l versus 241 x 10(9)/l in the control group). Accordingly, the levels of sP-selectin expressed per platelet increased to significantly higher levels (2.0 +/- 1.2 versus 0.6 +/- 0.2 fg/platelet in the control group; p < 0.0001). This suggests increased platelet turnover in patients with ITP. High levels of sP-selectin were found in patients with sepsis (398 +/- 203 ng/ml; n = 15) and with thrombotic thrombocytopenic purpura (TTP; 436 +/- 162 ng/ml; n = 12). Compared with patients with ITP, the concentration of sP-selectin per platelet was higher in patients with sepsis (4.8 +/- 4.3 fg/platelet; p < 0.005) or TTP (17.1 +/- 9.5 fg/platelet; p < 0.001). Endothelial cells are very likely to be the source in these patients and the presence of endothelial cell activation was confirmed by increased levels of circulating E-selectin and ED1-fibronectin. This study suggests that platelets are the major source of circulating sP-selectin in healthy individuals. Endothelial cell activation is associated with an increased sP-selectin concentration per platelet.
P-选择素是一种140kD的蛋白质,存在于血小板的α颗粒和内皮细胞的Weibel-Palade小体中。在细胞激活时,它表达于细胞表面并分泌到血浆中。循环中的可溶性P-选择素(sP-选择素)是来源于血小板、内皮细胞还是两者,目前尚不清楚。我们研究了不同血小板计数的疾病中sP-选择素的水平,这些疾病伴有或不伴有内皮细胞激活的证据。通过检测sE-选择素和ED1-纤维连接蛋白来确认内皮细胞激活。在健康对照者以及因骨髓再生障碍导致血小板减少或血小板增多症的患者中,观察到血小板计数与sP-选择素浓度之间存在显著正相关(r = 0.85;n = 47;p < 0.001)。特发性血小板减少性紫癜(ITP)患者的sP-选择素浓度为110±39 ng/ml(n = 10),而健康对照者为122±38 ng/ml(n = 26)。然而,ITP患者的平均血小板计数较低(58×10⁹/L,而对照组为241×10⁹/L)。因此,ITP患者每个血小板表达的sP-选择素水平显著升高(2.0±1.2对对照组的0.6±0.2 fg/血小板;p < 0.0001)。这表明ITP患者的血小板周转率增加。脓毒症患者(398±203 ng/ml;n = 15)和血栓性血小板减少性紫癜(TTP;436±162 ng/ml;n = 12)患者的sP-选择素水平较高。与ITP患者相比,脓毒症患者(4.8±4.3 fg/血小板;p < 0.005)或TTP患者(17.1±9.5 fg/血小板;p < 0.001)每个血小板的sP-选择素浓度更高。这些患者中内皮细胞很可能是来源,并且循环中E-选择素和ED1-纤维连接蛋白水平升高证实了内皮细胞激活。本研究表明,在健康个体中血小板是循环中sP-选择素的主要来源。内皮细胞激活与每个血小板的sP-选择素浓度增加有关。